Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01794663
What this trial is testing

Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function

Who this might be right for
Delayed Graft Function
Opsona Therapeutics Ltd. 252
Testing effectiveness (Phase 2)Study completedNCT03267121
What this trial is testing

Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115514
What this trial is testing

Treatment of ARDS With Instilled T3

Who this might be right for
ARDS, HumanLung, WetThyroid+2 more
University of Minnesota 68
Not applicableStudy completedNCT07113314
What this trial is testing

Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy

Who this might be right for
Febrile Neutropenia (FN)SepsisChemotherapy Treatment
Fondazione IRCCS Policlinico San Matteo di Pavia 160
Testing effectiveness (Phase 2)UnknownNCT00797784
What this trial is testing

The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus (DLE)
Florida Academic Dermatology Centers 20
Testing effectiveness (Phase 2)Ended earlyNCT03718533
What this trial is testing

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

Who this might be right for
Poor Graft Function
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Testing effectiveness (Phase 2)Looking for participantsNCT07509047
What this trial is testing

Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children

Who this might be right for
Cholera Vaccination
International Vaccine Institute 390
Testing effectiveness (Phase 2)Ended earlyNCT00983047
What this trial is testing

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00766038
What this trial is testing

Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

Who this might be right for
Traumatic Brain Injury
University of Pennsylvania 63
Testing effectiveness (Phase 2)Study completedNCT00914355
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 92
Testing effectiveness (Phase 2)Study completedNCT01957878
What this trial is testing

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL

Who this might be right for
Genital Infection ViralHUMAN PAPILLOMA VIRUS
Genticel 239
Testing effectiveness (Phase 2)Study completedNCT00247078
What this trial is testing

The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism

Who this might be right for
ArachnidismLatrodectism
Instituto Bioclon S.A. de C.V. 24
Testing effectiveness (Phase 2)Study completedNCT00994643
What this trial is testing

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Who this might be right for
High Risk Non-Hodgkin's Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 11
Testing effectiveness (Phase 2)UnknownNCT04553887
What this trial is testing

Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 53
Testing effectiveness (Phase 2)UnknownNCT00178763
What this trial is testing

Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer

Who this might be right for
Pancreatic Neoplasms
The University of Texas Health Science Center, Houston 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07723963
What this trial is testing

Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

Who this might be right for
Juvenile Myoclonic Epilepsy
Jazz Pharmaceuticals 260
Testing effectiveness (Phase 2)Study completedNCT01451593
What this trial is testing

Neuroprotection With Phenytoin in Optic Neuritis

Who this might be right for
Optic NeuritisMultiple Sclerosis
University College, London 92
Testing effectiveness (Phase 2)Looking for participantsNCT06567314
What this trial is testing

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01565616
What this trial is testing

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Emory University 22
Next Page